Interestingly, miR-93 has been shown to regulate AKT signaling in Cisplatin-resistant Ovarian Cancer cells (Fu et al., 2012) and miR-193 has been shown to be upregulated in TMZ- resistant GBM cells, but no target has been identified (Hiddingh et al., 2014). This evidence concerns the gene AKT1 and glioblastoma.